Related Experiment Video
Updated: May 24, 2026

Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay
Published on: February 7, 2025
Prevalence of RHD*DOL and RHCE*ce(818T) in two populations
C Halter Hipsky1, D C da Costa, R Omoto
1Laboratory of Immunochemistry, New York Blood Center, New York, NY 10065, USA.
Insights
The RHCE*ceBI allele, encoding the STEM antigen, is rare in African descent populations in the US and Brazil. Its presence is often linked with RHD*DOL alleles, important for blood transfusion compatibility.
Area of Science:
- Genetics
- Immunology
- Hematology
Background:
- The RHCE*ceBI and RHCE*ceSM alleles encode the low-prevalence Rh antigen STEM.
- These alleles are often found in cis with RHD*DOL, a significant factor in blood transfusion practices.
Purpose of the Study:
- To estimate the frequency of RHCE*ceBI and RHCE*ceSM alleles, particularly in relation to RHD*DOL.
- To investigate the prevalence of these specific Rh alleles in populations of African descent in the United States and Brazil.
Main Methods:
- Analysis of DNA from over 700 blood samples from sickle cell disease patients and blood donors of African descent.
- Standard DNA extraction and analysis techniques were employed.
Main Results:
- In the US, the frequency of RHCE*818T (RHCE*ceBI) was 0.007 (2/290), with one sample positive for RHD*DOL and another for RHD*DOL-2.
- In Brazil, the frequency of RHCE*818T was 0.004 (2/515).
- No RHD*DOL or RHD/RHD*DOL-2 alleles were found without RHCE*ce(818T) in over 500 additional tested samples.
Conclusions:
- The RHCE*818T allele (RHCE*ceBI) is infrequent in the studied populations of African descent.
- The co-occurrence of RHCE*818T with RHD*DOL alleles highlights potential complexities in blood group genotyping and transfusion compatibility.
Abstract:
The alleles RHCE*ceBI (RHCE*ce 48C, 712G, 818T, 1132G) and RHCE*ceSM (RHCE*ce 48C, 712G, 818T) encode the low-prevalence Rh antigen STEM. These alleles frequently travel in cis with RHD*DOL. To estimate the frequency of these alleles, we tested a total of more than 700 samples in two populations. Blood samples were obtained from patients with sickle cell disease and from blood donors of African descent. DNA extractions and analyses were performed by standard methods. In the United States, none of 70 patient samples had the RHCE*818 nucleotide change. Two of 220 donors (frequency of 0.009) were heterozygous for RHCE*818C/T (RHCE*ceBI). One of these samples had RHD/RHD*DOL and the other had RHD/RHD*DOL-2. In these 290 samples, no other RHD*DOL alleles were found. In Brazil, 1 of 244 patients with sickle cell disease (frequency of 0.004) and 1 of 171 donors (frequency of 0.006) were heterozygous for RHCE*818C/T (RHCE*ceBI). Testing of more than 500 additional samples from people of African descent, selected because they had a diverse range of common and variant RHCE alleles, did not reveal a sample with RHD*DOL or RHD/RHD*DOL-2 in the absence of RHCE*ce(818T). Although the numbers are small, our study shows that in the United States, the frequency of RHCE*818T is 0.007 (2 in 290 samples) and in Brazil it is 0.004 (2 in 515 samples). The four RHCE*818T alleles were RHCE*ceBI.
Related Concept Videos
Rh Blood Group
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...